Filings

1 document · 2 matches

1. TSHA Taysha Gene Therapies, Inc. 10-K 2026-03-19

   Item 1A. Risk Factors.

   material weaknesses in our internal control over financial reporting, we will be unable to assert that our internal control over
   2 matches in this document Show context Copy citation